— Know what they know.
Not Investment Advice

FHTX NASDAQ

Foghorn Therapeutics Inc.
1W: +3.0% 1M: -22.8% 3M: -27.4% YTD: -19.9% 1Y: +0.5% 3Y: -35.0% 5Y: -57.0%
$4.22
+0.06 (+1.44%)
 
Weekly Expected Move ±8.6%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $247.8M mcap · 27M float · 0.563% daily turnover · Short 58% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 28.2%
Cost Advantage
38
Intangibles
55
Switching Cost
44
Network Effect
63
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. FHTX shows a Weak competitive edge (45.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. ROIC of 28.2% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$12
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$11.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-17 Jefferies Initiated $12 +116.2% $5.55
2025-12-18 BTIG Initiated $11 +137.1% $4.64
2025-12-03 Stifel Nicolaus Initiated $12 +170.3% $4.44
2024-12-17 H.C. Wainwright Foghorn Therapeutics to $ Initiated $13 +107.7% $6.26
2024-09-24 Morgan Stanley Vikram Purohit $14 $9 -5 -3.4% $9.32
2024-08-19 Evercore ISI Gavin Clark-Gartner Initiated $20 +219.5% $6.26
2023-01-05 BMO Capital Initiated $20 +206.3% $6.53
2022-11-21 Morgan Stanley $15 $14 -1 +77.9% $7.87
2022-08-23 Morgan Stanley Vikram Purohit Initiated $15 +37.7% $10.89

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
May 22, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. FHTX receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-03-12 D+ C
2026-03-11 C D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

26 Grade D
Profitability
20
Balance Sheet
61
Earnings Quality
72
Growth
71
Value
23
Momentum
66
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. FHTX scores highest in Earnings Quality (72/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-4.30
Distress Zone
Piotroski F-Score
1/9
Beneish M-Score
-2.56
Unlikely Manipulator
Ohlson O-Score
-0.51
Bankruptcy prob: 37.5%
Moderate
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
OCF/NI: 1.16x
Accruals: 5.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. FHTX scores -4.30, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. FHTX scores 1/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. FHTX's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. FHTX's implied 37.5% bankruptcy probability is elevated and warrants attention to the balance sheet. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. FHTX receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-3.90x
PEG
-0.26x
P/S
8.78x
P/B
-3.84x
P/FCF
-3.80x
P/OCF
EV/EBITDA
-2.98x
EV/Revenue
7.61x
EV/EBIT
-2.87x
EV/FCF
-2.46x
Earnings Yield
-22.66%
FCF Yield
-26.30%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. FHTX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.005
EBT / EBIT
×
EBIT Margin
-2.656
EBIT / Rev
×
Asset Turnover
0.117
Rev / Assets
×
Equity Multiplier
-3.130
Assets / Equity
=
ROE
97.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. FHTX's ROE of 97.8% is driven by Asset Turnover (0.117), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1401 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$4.22
Median 1Y
$2.18
5th Pctile
$0.46
95th Pctile
$10.35
Ann. Volatility
89.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Adrian Gottschalk
President and Chief Executive Officer
$638,000 $— $2,361,027
Steven Bellon Science
cience Officer
$505,000 $— $1,199,455
Alfonso Quintás-Cardama Medical
edical Officer
$494,000 $— $1,133,965

CEO Pay Ratio

9:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,361,027
Avg Employee Cost (SGA/emp): $259,906
Employees: 106

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
106
-5.4% YoY
Revenue / Employee
$291,594
Rev: $30,909,000
Profit / Employee
$-700,783
NI: $-74,283,000
SGA / Employee
$259,906
Avg labor cost proxy
R&D / Employee
$806,283
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -45.7% -63.6% -83.4% -86.6% -90.1% -89.8% -2.2% -2.3% -2.4% -2.1% 2.6% 2.4% 2.2% 2.4% 1.4% 1.3% 1.2% 1.2% 96.5% 97.8% 97.81%
ROA -26.2% -36.4% -26.1% -27.1% -28.2% -28.2% -23.6% -24.3% -24.8% -22.3% -28.5% -26.9% -25.0% -26.4% -30.4% -28.2% -26.5% -25.3% -30.8% -31.2% -31.25%
ROIC -1.3% -1.7% -87.1% -91.1% -96.2% -98.0% 31.5% 32.9% 33.7% 30.7% 32.0% 30.5% 28.9% 30.9% 32.2% 30.5% 28.8% 27.1% 28.7% 28.2% 28.22%
ROCE -28.2% -39.3% -21.4% -22.4% -23.6% -24.1% -33.5% -35.1% -35.9% -32.7% -47.4% -45.2% -41.7% -44.7% -46.2% -43.8% -40.9% -37.2% -55.1% -54.2% -54.17%
Gross Margin -65.8% -498.9% -30.5% -5.3% -4.8% -3.1% -5.7% 1.0% -4.2% -50.2% 85.2% 1.0% 1.0% 1.0% 1.0% 1.0% 88.1% -1.5% 91.3% 92.7% 92.72%
Operating Margin -83.4% -640.5% -39.4% -7.1% -6.5% -4.3% -7.6% -6.3% -5.7% -97.7% -4.4% -5.6% -3.9% -3.1% -8.4% -3.8% -2.8% -2.3% -2.1% -6.6% -6.60%
Net Margin -82.8% -636.1% -40.9% -6.9% -6.1% -3.9% -6.9% -5.7% -5.3% -82.1% -4.2% -5.0% -3.3% -2.4% -6.8% -3.2% -2.4% -1.9% -2.3% -6.1% -6.08%
EBITDA Margin -80.6% -619.5% -38.2% -6.9% -6.3% -4.1% -7.4% -6.1% -5.6% -92.8% -4.3% -5.4% -3.4% -3.0% -8.1% -3.7% -2.3% -1.8% -2.0% -6.5% -6.53%
FCF Margin -76.9% -97.4% -40.6% 49.0% 25.4% 14.8% 10.0% -5.4% -5.2% -3.7% -3.5% -3.5% -3.1% -4.1% -4.5% -4.1% -3.8% -3.6% -2.8% -3.1% -3.10%
OCF Margin -64.1% -84.9% -38.1% 49.4% 25.5% 14.9% 10.1% -5.3% -5.2% -3.7% -3.5% -3.4% -3.1% -4.1% -4.4% -4.0% -3.7% -3.6% -2.8% -3.1% -3.10%
ROA 3Y Avg snapshot only -32.95%
ROIC Economic snapshot only 94.12%
Cash ROA snapshot only -44.12%
NOPAT Margin snapshot only -2.26%
Pretax Margin snapshot only -2.67%
R&D / Revenue snapshot only 2.91%
SGA / Revenue snapshot only 95.28%
SBC / Revenue snapshot only 26.07%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -5.88 -5.54 -8.35 -5.99 -5.16 -3.28 -2.45 -2.31 -2.57 -2.04 -2.77 -3.06 -3.43 -6.39 -3.41 -2.85 -3.93 -4.27 -4.58 -4.41 -3.896
P/S Ratio 481.82 600.95 641.05 127.21 61.61 22.69 13.87 12.57 13.55 6.45 7.98 8.40 8.43 22.84 13.07 9.76 12.24 12.57 11.00 11.78 8.779
P/B Ratio 2.69 3.52 8.73 6.50 5.83 3.69 2381.30 2314.54 2629.03 1876.16 -3.53 -3.69 -3.84 -7.55 -6.49 -5.04 -6.50 -6.77 -3.13 -3.06 -3.841
P/FCF -6.26 -6.17 -15.79 2.60 2.42 1.53 1.39 -2.34 -2.58 -1.74 -2.29 -2.43 -2.70 -5.61 -2.92 -2.39 -3.24 -3.47 -3.95 -3.80 -3.802
P/OCF 2.58 2.41 1.53 1.38
EV/EBITDA -4.47 -4.56 -7.69 -5.23 -4.34 -2.38 0.24 0.29 -0.00 0.76 -0.80 -0.96 -1.17 -4.00 -0.91 -0.25 -1.05 -1.31 -3.05 -2.98 -2.976
EV/Revenue 354.64 479.86 568.30 107.84 51.14 16.60 -1.43 -1.70 0.01 -2.58 2.45 2.82 3.06 15.44 3.93 0.97 3.70 4.14 7.20 7.61 7.610
EV/EBIT -4.33 -4.42 -7.44 -5.07 -4.21 -2.31 0.24 0.29 -0.00 0.74 -0.78 -0.93 -1.13 -3.87 -0.89 -0.24 -1.01 -1.26 -2.92 -2.87 -2.865
EV/FCF -4.61 -4.92 -13.99 2.20 2.01 1.12 -0.14 0.32 -0.00 0.70 -0.70 -0.82 -0.98 -3.79 -0.88 -0.24 -0.98 -1.14 -2.58 -2.46 -2.457
Earnings Yield -17.0% -18.0% -12.0% -16.7% -19.4% -30.5% -40.8% -43.4% -38.9% -49.1% -36.1% -32.7% -29.1% -15.7% -29.3% -35.1% -25.5% -23.4% -21.8% -22.7% -22.66%
FCF Yield -16.0% -16.2% -6.3% 38.5% 41.3% 65.3% 72.1% -42.7% -38.7% -57.6% -43.8% -41.1% -37.0% -17.8% -34.3% -41.8% -30.9% -28.8% -25.3% -26.3% -26.30%
EV/Gross Profit snapshot only 34.189
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 10.12 10.12 9.44 9.44 9.44 9.44 6.37 6.37 6.37 6.37 4.11 4.11 4.11 4.11 3.73 3.73 3.73 3.73 2.73 2.73 2.733
Quick Ratio 10.12 10.12 9.44 9.44 9.44 9.44 6.37 6.37 6.37 6.37 4.11 4.11 4.11 4.11 3.73 3.73 3.73 3.73 2.73 2.73 2.733
Debt/Equity 0.56 0.56 0.60 0.60 0.60 0.60 459.88 459.88 459.88 459.88 -0.58 -0.58 -0.58 -0.58 -0.82 -0.82 -0.82 -0.82 -0.38 -0.38 -0.380
Net Debt/Equity -0.71 -0.71 -0.99 -0.99 -0.99 -0.99 -2627.60 -2627.60 -2627.60 -2627.60
Debt/Assets 0.32 0.32 0.11 0.11 0.11 0.11 0.13 0.13 0.13 0.13 0.16 0.16 0.16 0.16 0.13 0.13 0.13 0.13 0.21 0.21 0.208
Debt/EBITDA -1.27 -0.91 -0.60 -0.57 -0.54 -0.53 -0.45 -0.43 -0.42 -0.46 -0.43 -0.45 -0.49 -0.46 -0.38 -0.40 -0.43 -0.48 -0.57 -0.57 -0.572
Net Debt/EBITDA 1.60 1.15 0.98 0.94 0.89 0.87 2.59 2.47 2.41 2.65 1.81 1.90 2.06 1.92 2.13 2.25 2.42 2.67 1.61 1.63 1.630
Interest Coverage -51.33 -51.69 -52.85 -74.23 -120.36 -266.04
Equity Multiplier 1.75 1.75 5.37 5.37 5.37 5.37 3615.03 3615.03 3615.03 3615.03 -3.70 -3.70 -3.70 -3.70 -6.24 -6.24 -6.24 -6.24 -1.83 -1.83 -1.826
Cash Ratio snapshot only 2.660
Cash to Debt snapshot only 3.850
FCF to Debt snapshot only -2.118
Defensive Interval snapshot only 666.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.00 0.00 0.00 0.01 0.02 0.04 0.04 0.04 0.05 0.07 0.10 0.10 0.10 0.07 0.08 0.08 0.08 0.09 0.13 0.12 0.117
Inventory Turnover
Receivables Turnover 0.01 0.03 0.06 0.11 0.13 0.14 0.14 0.22
Payables Turnover 10.31 15.88 21.42 22.96 24.92 26.64 22.88 17.57 18.28 18.13 9.65 9.65 4.64 0.15 0.00 0.00 0.18 4.16 5.39 5.45 5.451
DSO 0 0 41509 11054 5974 3475 2847 2656 2520 1681 0 0 0 0 0 0 0 0 0 0 0.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 35 23 17 16 15 14 16 21 20 20 38 38 79 2501 2037 88 68 67 67.0 days
Cash Conversion Cycle -35 -23 41492 11038 5960 3461 2831 2635 2500 1661 -38 -38 -79 -2501 -2037 -88 -68 -67 -67.0 days
Fixed Asset Turnover snapshot only 0.859
Cash Velocity snapshot only 0.178
Capital Intensity snapshot only 7.019
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.3% 8.2% 10.2% 17.4% 13.6% 3.2% 1.4% 1.1% 77.6% 64.4% 61.9% -21.7% -33.8% -30.7% -31.3% -3.9% 36.8% 20.1% 20.08%
Net Income -3.9% -1.4% -63.7% -17.4% -7.5% -6.8% -4.7% 5.4% 9.6% 17.3% 24.6% 11.6% 12.0% 13.5% 12.8% 20.9% 14.2% 6.4% 6.36%
EPS -1.6% -1.1% -45.3% -4.2% 5.0% -5.7% -4.0% 6.2% 10.6% 18.5% 38.8% 40.7% 40.6% 41.6% 28.6% 21.5% 14.8% 15.4% 15.37%
FCF -2.0% 6.6% 4.7% 3.8% 4.6% -1.5% -1.5% -1.5% -1.6% -5.7% 3.6% 14.1% 15.1% 18.0% 16.9% 14.5% 15.0% 8.8% 8.81%
EBITDA -3.9% -1.4% -67.0% -22.1% -16.7% -16.8% -13.0% -0.8% 8.2% 16.7% 25.0% 11.1% 7.0% 7.5% 6.7% 21.5% 25.0% 21.5% 21.47%
Op. Income -3.8% -1.4% -65.8% -21.3% -16.3% -16.4% -12.7% -0.9% 7.9% 16.2% 22.4% 8.9% 4.8% 5.2% 5.6% 16.9% 20.0% 17.1% 17.08%
OCF Growth snapshot only 8.03%
Asset Growth snapshot only -30.24%
Debt Growth snapshot only 11.15%
Shares Change snapshot only 10.65%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 4.1% 3.0% 2.5% 2.1% 1.6% 68.0% 38.2% 15.9% 17.1% 11.0% 11.04%
Revenue 5Y 1.6% 1.2% 1.21%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y
Gross Profit 5Y
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 3.8% 3.8% 3.8% 3.8% -18.2% -18.2% -18.2% -18.2% -21.2% -21.2% -21.20%
Assets 5Y -5.0% -5.0% -4.97%
Equity 3Y
Book Value 3Y
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.79 0.91 0.99 1.00 0.91 0.96 0.99 0.73 0.56 0.55 0.50 0.13 0.71 0.66 0.657
Earnings Stability 0.81 0.83 0.83 0.39 0.57 0.42 0.14 0.03 0.32 0.13 0.00 0.44 0.12 0.02 0.019
Margin Stability 0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.97 0.98 0.98 0.96 0.93 0.90 0.95 0.95 0.95 0.95 0.92 0.94 0.97 0.975
Earnings Smoothness
ROE Trend -971.57 -1003.38 -1022.69 -920.60
Gross Margin Trend 26.08 22.72 24.46 34.69 31.55 9.00 6.27 4.42 3.57 2.80 2.29 0.45 0.12 0.05 0.054
FCF Margin Trend 66.45 10.25 20.51 37.60 11.81 -25.26 -13.21 -9.62 -7.74 0.33 0.41 0.27 1.20 0.67 0.667
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.78 0.78 0.50 -2.32 -2.14 -2.15 -1.78 0.97 0.98 1.16 1.20 1.25 1.27 1.13 1.16 1.18 1.20 1.22 1.16 1.16 1.160
FCF/OCF 1.20 1.15 1.07 0.99 1.00 1.00 0.99 1.01 1.02 1.01 1.01 1.01 1.00 1.00 1.01 1.01 1.01 1.01 1.00 1.00 1.000
FCF/Net Income snapshot only 1.161
CapEx/Revenue 12.9% 12.5% 2.5% 35.7% 10.1% 6.5% 6.3% 7.8% 7.8% 4.5% 3.6% 2.0% 0.7% 1.8% 4.0% 3.5% 3.5% 2.2% 0.2% 0.1% 0.08%
CapEx/Depreciation snapshot only 0.008
Accruals Ratio -0.06 -0.08 -0.13 -0.90 -0.89 -0.89 -0.65 -0.01 -0.01 0.04 0.06 0.07 0.07 0.04 0.05 0.05 0.05 0.06 0.05 0.05 0.050
Sloan Accruals snapshot only -0.340
Cash Flow Adequacy snapshot only -3972.591
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -31.5% -24.0% 0.0% -0.1% -0.3% -0.5% -0.7% -0.5% -0.2% -0.1% -0.0% -0.0% -34.9% -18.0% -35.5% -45.8% -0.6% -0.1% -0.3% -15.3% -15.31%
Total Shareholder Return -31.5% -24.0% 0.0% -0.1% -0.3% -0.5% -0.7% -0.5% -0.2% -0.1% -0.0% -0.0% -34.9% -18.0% -35.5% -45.8% -0.6% -0.1% -0.3% -15.3% -15.31%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.02 1.04 1.04 1.03 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.01 1.00 0.98 0.96 0.93 0.91 0.90 0.88 0.87 0.87 0.88 0.88 0.86 0.85 0.85 0.89 0.97 1.00 1.005
EBIT Margin -81.90 -108.62 -76.37 -21.28 -12.15 -7.19 -6.09 -5.95 -5.78 -3.51 -3.16 -3.03 -2.70 -3.99 -4.44 -4.04 -3.67 -3.29 -2.47 -2.66 -2.656
Asset Turnover 0.00 0.00 0.00 0.01 0.02 0.04 0.04 0.04 0.05 0.07 0.10 0.10 0.10 0.07 0.08 0.08 0.08 0.09 0.13 0.12 0.117
Equity Multiplier 1.75 1.75 3.19 3.19 3.19 3.19 9.53 9.53 9.53 9.53 -8.96 -8.96 -8.96 -8.96 -4.64 -4.64 -4.64 -4.64 -3.13 -3.13 -3.130
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.81 $-2.51 $-2.74 $-2.54 $-2.64 $-2.62 $-2.60 $-2.69 $-2.74 $-2.46 $-2.33 $-2.19 $-1.68 $-1.46 $-1.38 $-1.28 $-1.20 $-1.14 $-1.18 $-1.08 $-1.08
Book Value/Share $3.97 $3.95 $2.62 $2.34 $2.33 $2.32 $0.00 $0.00 $0.00 $0.00 $-1.83 $-1.82 $-1.50 $-1.23 $-0.73 $-0.72 $-0.72 $-0.72 $-1.72 $-1.56 $-1.10
Tangible Book/Share $3.97 $3.95 $2.62 $2.34 $2.33 $2.32 $0.00 $0.00 $0.00 $0.00 $-1.83 $-1.82 $-1.50 $-1.23 $-0.73 $-0.72 $-0.72 $-0.72 $-1.72 $-1.56 $-1.56
Revenue/Share $0.02 $0.02 $0.04 $0.12 $0.22 $0.38 $0.46 $0.49 $0.52 $0.77 $0.81 $0.80 $0.68 $0.41 $0.36 $0.37 $0.38 $0.39 $0.49 $0.41 $0.41
FCF/Share $-1.70 $-2.26 $-1.45 $5.87 $5.61 $5.60 $4.60 $-2.65 $-2.72 $-2.88 $-2.82 $-2.76 $-2.13 $-1.66 $-1.62 $-1.53 $-1.45 $-1.41 $-1.37 $-1.26 $-1.26
OCF/Share $-1.42 $-1.97 $-1.36 $5.91 $5.63 $5.63 $4.63 $-2.61 $-2.68 $-2.84 $-2.79 $-2.74 $-2.13 $-1.65 $-1.60 $-1.51 $-1.44 $-1.40 $-1.37 $-1.26 $-1.26
Cash/Share $5.04 $5.02 $4.17 $3.73 $3.72 $3.70 $8.27 $8.27 $8.27 $8.23 $5.54 $5.52 $4.54 $3.74 $3.89 $3.88 $3.87 $3.87 $2.52 $2.28 $2.66
EBITDA/Share $-1.76 $-2.44 $-2.64 $-2.47 $-2.60 $-2.64 $-2.72 $-2.85 $-2.92 $-2.64 $-2.47 $-2.34 $-1.78 $-1.57 $-1.55 $-1.46 $-1.36 $-1.23 $-1.16 $-1.04 $-1.04
Debt/Share $2.23 $2.22 $1.58 $1.41 $1.41 $1.40 $1.23 $1.23 $1.23 $1.23 $1.07 $1.06 $0.87 $0.72 $0.59 $0.59 $0.59 $0.59 $0.66 $0.59 $0.59
Net Debt/Share $-2.82 $-2.81 $-2.60 $-2.32 $-2.31 $-2.30 $-7.04 $-7.04 $-7.04 $-7.00 $-4.47 $-4.45 $-3.66 $-3.02 $-3.30 $-3.29 $-3.28 $-3.28 $-1.87 $-1.69 $-1.69
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -4.298
Altman Z-Prime snapshot only -8.385
Piotroski F-Score 2 2 3 5 5 6 4 3 3 2 2 2 3 1 2 1 1 1 1 1 1
Beneish M-Score -1.64 11.89 14.86 223.69 -0.12 -6.39 -3.10 1.06 -5.99 -2.28 -4.75 -3.86 -3.07 -2.20 -2.20 -3.20 0.07 -2.56 -2.561
Ohlson O-Score snapshot only -0.512
Net-Net WC snapshot only $-2.06
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B-
Credit Score 37.28 37.95 32.99 40.94 41.55 41.98 42.23 35.29 34.85 35.22 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 30
Sector Credit Rank snapshot only 28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms